Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kun Xiao, Pengfei Liu, Peng Yan, Yanxin Liu, Licheng Song, Yuhong Liu & Lixin Xie. (2022) N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways. Bioengineered 13:5, pages 11973-11986.
Read now
Read now
Qi Pan, Jing Xu, Cen-Jin Wen, Yu-Yan Xiong, Zhao-Ting Gong & Yue-Jin Yang. (2021) Nanoparticles: Promising Tools for the Treatment and Prevention of Myocardial Infarction. International Journal of Nanomedicine 16, pages 6719-6747.
Read now
Read now
Ke Lei, Bing Ma, Ping Shi, Che Jin, Tan Ling, Longjiang Li, Xiangyi He & Lunchang Wang. (2020) Icariin Mitigates the Growth and Invasion Ability of Human Oral Squamous Cell Carcinoma via Inhibiting Toll-Like Receptor 4 and Phosphorylation of NF-κB P65. OncoTargets and Therapy 13, pages 299-307.
Read now
Read now
Jie Yang, Kailing Li, Dan He, Jing Gu, Jingyu Xu, Jiaxi Xie, Min Zhang, Yuying Liu, Qunyou Tan & Jingqing Zhang. (2020) Toward a better understanding of metabolic and pharmacokinetic characteristics of low-solubility, low-permeability natural medicines. Drug Metabolism Reviews 52:1, pages 19-43.
Read now
Read now
Articles from other publishers (9)
Yuxin Wan, Zhenze Xie, Mingjie Wang, Yuelian Liu, Mubin Zheng, Dong Xu & Chang Du. (2023) Esterase-triggered rapid release of succinic anhydride conjugated curcumin co-prodrug for osteosarcoma therapy. European Polymer Journal 198, pages 112382.
Crossref
Crossref
Yuling Wang, Chang Shang, Yang Zhang, Laiyun Xin, Linke Jiao, Mi Xiang, Zihuan Shen, Chen Chen, Fan Ding, Yingdong Lu & Xiangning Cui. (2023) Regulatory mechanism of icariin in cardiovascular and neurological diseases. Biomedicine & Pharmacotherapy 158, pages 114156.
Crossref
Crossref
Prasanti SharmaNeelima Sharma. (2022) Advances in Nanoformulated Polyphenols for Protection Against Cardiovascular Diseases. Journal of Cardiovascular Pharmacology 80:5, pages 648-660.
Crossref
Crossref
Jinghan Li, Yakun Yang, Hua Wang, Donglai Ma, Hongfang Wang, Li Chu, Yuanyuan Zhang & Yonggang Gao. (2022) Baicalein Ameliorates Myocardial Ischemia Through Reduction of Oxidative Stress, Inflammation and Apoptosis via TLR4/MyD88/MAPKS/NF-κB Pathway and Regulation of Ca2+ Homeostasis by L-type Ca2+ Channels. Frontiers in Pharmacology 13.
Crossref
Crossref
Yufei Zeng, Yilin Xiong, Tao Yang, Yan Wang, Jing Zeng, Shaoyu Zhou, Yunmei Luo & Lisheng Li. (2022) Icariin and its metabolites as potential protective phytochemicals against cardiovascular disease: From effects to molecular mechanisms. Biomedicine & Pharmacotherapy 147, pages 112642.
Crossref
Crossref
Paulina Hernández-Fontes, Omar Lozano & Gerardo García-Rivas. 2021. Mitochondrial Dysfunction and Nanotherapeutics. Mitochondrial Dysfunction and Nanotherapeutics
311
347
.
Nabil A. Alhakamy, Usama A. Fahmy, Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, Hani Z. Asfour, Hibah M. Aldawsari, Mardi M. Algandaby, Basma G. Eid, Ashraf B. Abdel-Naim, Zuhier A. Awan, Nabil K. Alruwaili & Amir I. Mohamed. (2020) Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer Cells. Pharmaceutics 12:4, pages 346.
Crossref
Crossref
Tingjuan Ni, Na Lin, Xingxiao Huang, Wenqiang Lu, Zhenzhu Sun, Jie Zhang, Hui Lin, Jufang Chi & Hangyuan Guo. (2020) Icariin Ameliorates Diabetic Cardiomyopathy Through Apelin/Sirt3 Signalling to Improve Mitochondrial Dysfunction. Frontiers in Pharmacology 11.
Crossref
Crossref
Leila Arabi, Jim Q. Ho, Najmeh Javdani, Mohammed Sharaf, Michelle Lam, Morteza Aieneravaie, Petrina Georgala, Mohammad Reza Sepand, Marjan Rafat & Steven Zanganeh. 2020. Nanomedicine for Ischemic Cardiomyopathy. Nanomedicine for Ischemic Cardiomyopathy
143
156
.